PodcastIntel
Sign in Get Started Free
Dr. Alex Tatem

FDA Just Changed the Future of Peptides

Jul 24, 2026 · 0:05:41
Listen to Episode
✨ AI Summary
  • FDA committee recommended BPC-157, TB-500, MOTS-c, KPV for bulk listing.
  • This is not final approval; further steps are required.
  • Dr. Tatem clarifies the implications of the FDA's decision.

More from Dr. Alex Tatem

Sermorelin: The “Safer HGH” Has One Huge Problem
Aug 18, 2026 · 0:25:00
Primobolan: The Steroid Everyone Gets Wrong
Aug 12, 2026 · 0:26:45
Doctor Reacts to Clav’s Insane Drug Stack
Aug 10, 2026 · 0:02:15
The Truth About NAD (From a Doctor)
Aug 4, 2026 · 0:22:07
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Dr. Alex Tatem and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →